So what about insurers in the US - with insurance a testosterone treatment is about $97 pcm, and without about $440 pcm from one source. http://www.drugs.com/comments/testosterone/
Big diff. Might insurers not tighten requirements for insurance coverage? Could be an earnings risk before any study is completed, as they may only cover for hypogonadism. Maybe that is all they cover ATM anyway?
Not sure what proportion of patients is getting the insured price.
If anybody knows a bit about the insurance angle - would love to hear it.
cheers
- Forums
- ASX - By Stock
- ACR
- FDA questions efficacy of testosterone and whether risks really do exist
ACR
acrux limited
Add to My Watchlist
0.00%
!
1.9¢

FDA questions efficacy of testosterone and whether risks really do exist, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.747M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.9¢ | $5.562K | 292.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 381825 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 60000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 331825 | 0.019 |
3 | 381800 | 0.018 |
1 | 175000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 60000 | 2 |
0.021 | 177000 | 1 |
0.022 | 18000 | 1 |
0.023 | 73278 | 3 |
0.024 | 254102 | 7 |
Last trade - 15.04pm 20/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |